Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × selinexor × Clear all

Status

Active not recruiting 1

Sponsor Class

OTHER 81 INDUSTRY 33 NIH 5 NETWORK 3 OTHER_GOV 1 FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1 Plasma cell 1

Conditions

Multiple Myeloma 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Exercise 6 pembrolizumab 5 sargramostim 3 enzalutamide 3 Imiquimod 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Cryotherapy 3 Colonoscopy 3 Celecoxib 3 Abiraterone Acetate 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 apalutamide 2 Yoga 2 Topotecan 2 Testosterone 2 Tablets 2 Simvastatin 2 Radiosurgery 2 Palliative Care 2 Midazolam 2 Methods 2 Leuprolide 2 Itraconazole 2 Gelatin 2 Docetaxel 2 Decision Support Techniques 2 Clofarabine 2 Capecitabine 2 talabostat 1 sulforaphane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06452446 2025-02-10

Selinexor

Durham VA Medical Center

Active not recruiting

Plasma cellSarcoma

Multiple Myeloma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡